← FDA Drug Approvals (Drugs@FDA)
ARIPIPRAZOLE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2018-04-18
Drug application
- FDA Application #
ANDA207240- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ARIPIPRAZOLE
- Generic name
- ARIPIPRAZOLE ORALLY DISINTEGRATING
- Active ingredients
- ARIPIPRAZOLE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- Manufacturer
- Dr. Reddy's Laboratories Inc
- First approval
- 2018-04-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown